erythritol - CISMeF

Preferred Label : erythritol;

MeSH definition : A four-carbon sugar that is found in algae, fungi, and lichens. It is twice as sweet as sucrose and can be used as a coronary vasodilator.;

MeSH CAS label : 1,2,3,4-Butanetetrol, (R*,S*)-;

MeSH Related Number : 149-32-6 (Erythritol);

Registry Number MeSH : 149-32-6;

Wikipedia link : https://en.wikipedia.org/wiki/Erythritol;

Codes EINECS : 205-737-3;

Is substance : O;

UNII : RA96B954X6;

InChIKey : UNXHWFMMPAWVPI-ZXZARUISSA-N;

Details

Origin ID

D004896;

UMLS CUI

C0014757;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- erythritol [Substance BNPC]
Currated CISMeF NLP mapping
- Erythritol [LOINC component]
Pharmacological action(s)
- vasodilator agents [MeSH Descriptor]
Record concept(s)
- erythritol [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1'-((1,4-dideoxy-1,4-iminoarabinitol)-4-N-ammonium)-1'-deoxyerythritol-3'-sulfate [MeSH Supplementary Concept]
- 1,3,4,5-tetragalloylapiitol [MeSH Supplementary Concept]
- 1,4-anhydroerythritol [MeSH Supplementary Concept]
- 2,3-O-isopropylideneerythritol [MeSH Supplementary Concept]
- 2,3-anhydroerythritol [MeSH Supplementary Concept]
- 2-C-methyl-1,3,4-triacetylerythritol [MeSH Supplementary Concept]
- 2-C-methylerythritol 4-phosphate [MeSH Supplementary Concept]
- 2-C-trifluoromethylerythritol [MeSH Supplementary Concept]
- 2-methyl-D-erythritol-4-phosphate [MeSH Supplementary Concept]
- 2-methyl-L-erythritol-1-O-(6-O-trans-sinapoyl)-beta-D-glucopyranoside [MeSH Supplementary Concept]
- 2-methyl-L-erythritol-4-O-(6-O-trans-sinapoyl)-beta-D-glucopyranoside [MeSH Supplementary Concept]
- 2-methyl-butan-1,2,3,4-tetraol-2,4-cyclopyrophosphate [MeSH Supplementary Concept]
- 3-(hydroxymethyl)erythritol [MeSH Supplementary Concept]
- 3-C-methylerythritol [MeSH Supplementary Concept]
- 4-O-(3,4-O-(1-carboxyethylidene)-beta-galactopyranosyl)erithritol [MeSH Supplementary Concept]
- 4-diphosphocytidyl-2-C-methylerythritol [MeSH Supplementary Concept]
- 4-diphosphocytidyl-2C methylerythritol 2-phosphate [MeSH Supplementary Concept]
- FCH(2)-methyl-D-erythritol 4-phosphate [MeSH Supplementary Concept]
- bis(meso-oxolanediolato)borate [MeSH Supplementary Concept]
- diacylmannosylerythritol [MeSH Supplementary Concept]
- erythritol 4-phosphate [MeSH Supplementary Concept]
- erythritol methacrylate [MeSH Supplementary Concept]
- kelletinin I [MeSH Supplementary Concept]
- methyl-D-erythritol 2,4-cyclodiphosphate [MeSH Supplementary Concept]
- orsellinylmontagnetol A [MeSH Supplementary Concept]
- pentaerythritol dinitrate [MeSH Supplementary Concept]
- phosphoric acid 3-fluoro-2,4-dihdyroxy-3-methylbutyl ester [MeSH Supplementary Concept]
- ritrosulfan [MeSH Supplementary Concept]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Erythritol [LOINC component]
- erythritol [Substance BNPC]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients